Brain-Computer Interface2
Intretech to Acquire 41% Stake in Beiyang Ruiheng for 2.05 Million Yuan in Related-Party Deal
Intretech announced on October 8 that it plans to use its own funds of 2.05 million yuan to acquire a 41% stake in Xiamen Beiyang Ruiheng Smart Health Co., Ltd. from the Xiamen Beiyang Brain-Computer Interface and Smart Health Innovation Research Institute. Upon completion, Intretech will hold 41% of Beiyang Ruiheng. The transaction constitutes a related-party deal because company chairman Lin Songhua serves as a director of Beiyang Ruiheng and holds a 10% stake in it. In the first half of 2026, Intretech achieved revenue of 2.552 billion yuan and net profit attributable to the parent of 338 million yuan.
About megatrends
Brain-Computer Interface › Non-invasive BCI & Neurotech Capital
002925.CS · Capital · Neutral Intretech plans to acquire a 41% stake in Beiyang Ruiheng for 2.05 million yuan in a related-party deal.
厦门北洋瑞恒智慧健康有限公司 · Capital · Neutral Beiyang Ruiheng is the target of Intretech's 41% stake acquisition in a related-party transaction.